Answers are grounded in this paper and cite their sources.
In mammals, tropomyosin is encoded by four known TPM genes (TPM1, TPM2, TPM3, and TPM4) each of which can generate a number of TPM isoforms via alternative splicing and/or using alternate promoters. In humans, the sarcomeric isoform(s) of each of the TPM genes, except for the TPM4, have been known for a long time. Recently, on the basis of computational analyses of the human genome sequence, the predicted sequence of TPM4 α has been posted in GenBank. We designed primer-pairs for RT-PCR and showed the expression of the transcripts of TPM4 α and a novel isoform TPM4 δ in human heart and skeletal muscle. qRT-PCR shows that the relative expression of TPM4 α and TPM4 δ is higher in human cardiac muscle. Western blot analyses using CH1 monoclonal antibodies show the absence of the expression of TPM4 δ protein (~28 kDa) in human heart muscle. 2D western blot analyses with the same antibody show the expression of at least nine distinct tropomyosin molecules with a mass ~32 kD and above in adult heart. By Mass spectrometry, we determined the amino acid sequences of the extracted proteins from these spots. Spot “G” reveals the putative expression of TPM4 α along with TPM1 α protein in human adult heart.
No takes yet. Share an insight, caveat, or question.
Dube et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: